Abstract-In a previous work, we postulated that endothelial cells possess only the following 2 enzymes involved in prostanoid synthesis: cyclooxygenase and prostacyclin synthase. The present work focused on investigating the expression of prostaglandin (PG) E synthase (PGES) in vascular cells. Key Words: prostaglandin E synthase Ⅲ endothelium Ⅲ smooth muscle Ⅲ prostanoid Ⅲ cytokine T he potent relaxing and platelet antiaggregation agent prostaglandin (PG) I 2 (also termed prostacyclin) is the characteristic prostanoid released by vascular endothelial 1 and smooth muscle cells (SMCs). 2 PGE 2 is also a major prostanoid found to be produced in vitro by vascular cells in response to different agents, which include exogenously added arachidonic acid (AA) and several agonists. 1,3-5 Cyclooxygenase (COX, also termed PGH synthase) is the first enzyme in the biosynthesis of prostanoids. Two COX isoforms have been described. COX-1 is expressed in a constitutive manner, whereas COX-2 is the isoenzyme inducible by mitogens and overexpressed in inflammatory processes. 6 COX catalyzes the transformation of AA to PGH 2 , which has constricting and platelet-activating properties, because both thromboxane A 2 and PGH 2 share the same receptor. 7 Prostacyclin synthase (PGI synthase; PGIS) catalyzes the subsequent transformation of PGH 2 into PGI 2 . Isomerization of PGH 2 to PGE 2 may occur spontaneously 8 or may be enzymatically catalyzed by a PGE synthase (PGES). The enzyme responsible for this isomerization was little known until the recent report by Jakobsson et al, 9 who identified and characterized the human PGES as a membrane-bound enzyme of which the activity is glutathione-dependent and inducible by interleukin (IL)-1␤.
T he potent relaxing and platelet antiaggregation agent prostaglandin (PG) I 2 (also termed prostacyclin) is the characteristic prostanoid released by vascular endothelial 1 and smooth muscle cells (SMCs). 2 PGE 2 is also a major prostanoid found to be produced in vitro by vascular cells in response to different agents, which include exogenously added arachidonic acid (AA) and several agonists. 1, [3] [4] [5] Cyclooxygenase (COX, also termed PGH synthase) is the first enzyme in the biosynthesis of prostanoids. Two COX isoforms have been described. COX-1 is expressed in a constitutive manner, whereas COX-2 is the isoenzyme inducible by mitogens and overexpressed in inflammatory processes. 6 COX catalyzes the transformation of AA to PGH 2 , which has constricting and platelet-activating properties, because both thromboxane A 2 and PGH 2 share the same receptor. 7 Prostacyclin synthase (PGI synthase; PGIS) catalyzes the subsequent transformation of PGH 2 into PGI 2 . Isomerization of PGH 2 to PGE 2 may occur spontaneously 8 or may be enzymatically catalyzed by a PGE synthase (PGES). The enzyme responsible for this isomerization was little known until the recent report by Jakobsson et al, 9 who identified and characterized the human PGES as a membrane-bound enzyme of which the activity is glutathione-dependent and inducible by interleukin (IL)-1␤.
We reported that endothelial cells released untransformed PGH 2 when COX activity increased and PGIS decreased as a result of the action of IL-1␤. 5, 10 Although endothelial cells produced PGE 2 as a major prostanoid, in particular after cytokine stimulation, on the basis of indirect evidence we postulated that endothelial cells possess only 3 enzymes involved in the biosynthesis of prostanoids COX-1, COX-2, and PGIS. 5 Because expression of PGES could not only modulate synthesis of PGE 2 but could also modulate the release of untransformed PGH 2 or even PGI 2 by diverting metabolism of PGH 2 , this study was conducted to investigate the expression of PGES on vascular cells and its modulation by mitogens and cytokines.
Materials and Methods

Cell Culture and Treatment
Human umbilical vein endothelial cells (HUVECs) were cultured as previously described. 11 HUVECs in first passage were maintained without heparin and endothelial cell growth factor for 48 hours before the addition (or not) of 10 nmol/L phorbol 12-myristate 13-acetate (PMA, Sigma), 10 U/mL human recombinant IL-1␤ (Boehringer Mannheim), 20 ng/mL recombinant human tumor necrosis factor (TNF)-␣ (Promega), or 100 g/mL of lipopolysaccharide (LPS, Escherichia coli serotype 0111:B4, Sigma) in M199 12 Cells in passages 4 to 6 were maintained with 1% FBS for 48 hours before treatment with PMA, IL-1␤, TNF-␣, or LPS as described above.
SMCs were isolated from human popliteal artery by an explant procedure. The artery was split longitudinally, and the endothelium was removed by gently scraping. The tissue was minced and seeded onto the culture surface in a small volume of DMEM containing 10% FBS. SMCs were characterized by ␣-actin-positive staining. Cells in passages 4 to 7 were maintained with 1% FBS for 48 hours before treatment with PMA, IL-1␤, TNF-␣, or LPS as described above.
Determination of AA Metabolism in the Presence or Absence of SnCl 2
After treatment with the stimuli, cells were incubated in the presence of 25 mol/L [ 14 C]AA (55 to 58 mCi/mmol, Amersham) as described. 5 To estimate the untransformed PGH 2 released, we calculated the difference between the PGF 2␣ peak of the samples from cells incubated as aforementioned and cells incubated in the presence of 200 g/mL SnCl 2 as described. 5 Prostanoids were analyzed by HPLC as described. 13 
Expression of PGES
After cell treatment with the stimuli, total RNA was isolated and reverse-transcribed into cDNA and then subjected to a polymerase chain reaction (PCR) protocol as previously described for COX-1 and COX-2. 12 Serial half-dilutions of the cDNA were performed to test linearity. Specific primers (Progenetic SL) for PCR based on the open reading frame of the microsomal glutathione-dependent PGES sequence described 9 were synthesized. The sequence of the sense and antisense primers for human PGES were 5Ј-CTCTGCA-GCACGCTGCTGG-3Ј (sense) and 5Ј-GTAGGTCACGGAG-CGGATGG-3Ј (antisense). This primer pair yielded an amplified product of the expected size of 344 bp. After an initial denaturation for 5 minutes at 94°C, 27 cycles of amplification (94°C for 45 seconds, 65°C for 45 seconds, and 72°C for 45 seconds) were performed, followed by a 10-minute extension at 72°C, for all the samples. The amplification products were separated by electrophoresis, and the radioactivity associated with the specific band was evaluated and normalized to GAPDH as previously described. 12 
Results
Prostanoid synthesis by SMCs was characterized by the formation of PGE 2 and PGI 2 (evaluated as 6-oxo-PGF 1␣ ); PGF 2␣ was not detected in the absence of SnCl 2 . When SnCl 2 was present in the incubation mixture, only a small amount of PGE 2 was deviated toward PGF 2␣ , whereas formation of PGI 2 was not modified by SnCl 2 . For comparative purposes human dermal fibroblasts were included in the study, their prostanoid profile being similar to that of SMCs (Figure 1) . PMA, LPS, IL-1␤, and TNF-␣ significantly increased the formation of PGE 2 in SMCs (Table) . Formation of PGI 2 was significantly increased only by PMA, IL-1␤, and TNF-␣.
As expected, resting and treated HUVECs incubated with [
14 C]AA produced PGI 2 (evaluated as 6-oxo-PGF 1␣ ), PGE 2 , PGF 2␣ , and PGD 2 as prostanoids. Cell treatment with the stimuli caused an increased production of prostanoids in HUVECs. Nevertheless, the net effect of PMA, IL-1␤, TNF-␣, and LPS on each particular prostanoid was not uniform (Table) . PGE 2 and PGD 2 were the main prostanoids increased by all of the inductors (Table) . The formation of PGI 2 was only minimally modified by the presence of SnCl 2 in the medium. In contrast, PGE 2 and PGD 2 completely disappeared in the samples containing SnCl 2 , and the levels of PGF 2␣ increased concomitantly (Figure 1 ). Reverse transcriptase (RT)-PCR analysis of mRNA encoding for PGES showed that the enzyme was expressed in SMCs and dermal fibroblasts but not in HUVECs and in SVECs. PGES was strongly induced by IL-1␤ and TNF-␣, with IL-1␤ being the most potent (Figure 2 ). PMA and LPS also significantly induced PGES but to a lesser extent. Twenty-seven cycles of PCR were usually performed for linearity, although no band corresponding to PGES was detected in HUVECs and SVECs even after 35 cycles of PCR (not shown).
Discussion
The present results clearly indicate that endothelial cells from fetal and adult vessels did not express PGES even after treatment with the cytokines, PMA, or LPS. It is well known that culture conditions influence AA metabolism in endothelial cells. It has been reported that COX is downregulated by endothelial cell growth factor and heparin. 14 -18 Under our experimental conditions, endothelial cells were maintained without heparin and endothelial cell growth factor for 48 hours before the addition (or not) of PMA, IL-1␤, TNF-␣, or LPS to maximize prostanoid formation. An even more important factor that regulates AA metabolism in cultured endothelial cells is the number of subcultivations. It has been reported that subcultivation negatively influences PGI 2 formation by endothelial cells. 19, 20 Indeed, we also observed that HUVECs lose their ability to form PGI 2 as the number of passages increase. The loss of activities of both COX and PGIS was related to a diminution of the expression of COX-1 and PGIS, with the loss of PGIS being faster than that of COX-1 in terms of mRNA (unpublished results). The present results were obtained from experiments performed with HUVECs and SVECs at first and second passage, respectively, to maximize COX and PGIS activities and to prevent the hypothetical loss of PGES expression with the number of passages.
In contrast, PGES was expressed in resting and stimulated SMCs and dermal fibroblasts. Consistently with the report of Jakobsson et al, 9 PGES was inducible by IL-1␤ in SMCs and fibroblasts but also by TNF-␣, PMA, and LPS, which indicated that it is probably induced under inflammatory conditions. Our results are also consistent with previous reports that PGE 2 is the most commonly induced prostanoid by IL-1␤ in SMCs, although in these works PGES expression was not analyzed. 21, 22 Matsumoto et al 23 observed that LPS induced COX-2 expression and enhanced PGES activity in rat macrophages. The fact that not only PGE 2 but also PGI 2 was increased by PMA, IL-1␤, and TNF-␣ in SMCs was due to the induction of COX-2 (evaluated by RT-PCR and Western blotting [not shown]) by these agents, which indicates that formation of PGI 2 in SMCs is limited by COX activity rather than by PGIS.
PGIS and PGES compete for the substrate because both PGIS and PGES have the same substrate (PGH 2 ) and, like COX, both are located in the microsomal fraction. On the other hand, whereas PGES is an inducible enzyme, 9 PGIS is not. 5 The substrate distribution between PGIS and PGES is primarily governed by the relative affinity each enzyme has for the substrate. Experiments performed with preparations of purified bovine PGIS showed a K m of 7.3 to 9 mol/L. 24, 25 K m values for PGES purified from rat tissues were between 25.5 and 82.6 mol/L, 26 and when purified from sheep vesicular glands, the K m value was 40 mol/L. 27 Unfortunately, there are still no data in the literature about the kinetic parameters of the human enzymes or even kinetic studies performed with PGIS and PGES preparations of the same species. In any case, theoretically, a modification in the proportion of PGIS and PGES molecules would probably influence the relative amount of PGI 2 and PGE 2 formed in a particular cell that expresses both enzymes. Hence, the induction of PGES could indirectly influence PGI 2 formation. Results from experiments incubating cells with labeled AA showed a PGE 2 /PGI 2 ratio of 1.8Ϯ0.2 and 2.2Ϯ0.5 (meanϮSD, nϭ6) in controls and in IL-1␤-treated SMCs, respectively. This variation was in fact less apparent than expected. This could be due to the fact that other factors such as a different velocity of suicide inactivation of the PGIS and PGES and the total COX activity could also influence the relative amount of PGI 2 and PGE 2 formed under a particular condition.
More apparent was the effect of PGES expression on the release of untransformed PGH 2 , which has activity opposite that of PGI 2 . Although COX-2 was induced (not shown), treatment of SMCs with IL-1␤ resulted in a significant decrease in their ability to release untransformed PGH 2 , which was likely a result of a concomitant induction of PGES. In contrast, COX-2 induction in HUVECs resulted in an enhanced ability to release the vasoconstricting prostanoid PGH 2 . 5 The present results suggest that SMCs do not contribute to the release of PGH 2 even under inflammatory conditions and reinforce the concept that release of PGH 2 by vascular endothelial cells is exclusively regulated by the ratio of COX to PGIS activity. 5, 10 More research is needed to ascertain PGES expression under pathological conditions and in other endothelial cell phenotypes such as capillary endothelial cells.
